The invention relates to the use of biotin for treating multiple sclerosis, in particular of the progressive forms and of the neurological sequelae, wherein the treatment with biotin has a duration of at least 3 months.Biotin za upotrebu u tretmanu multiple skleroze.Prijava sadrži još 12 patentnih zahteva.